Skip to main navigation
Orchestra BioMed logo

Close

Investor Relations
  • Who We Are
    • Our Approach
    • Our People
    • Careers
  • Our Innovations
    • Pipeline
    • Therapeutic Areas
    • Virtue® SAB
    • BackBeat CNT™
    • FreeHold Retractors
  • Investor Relations
  • News & Events
    • News Releases
    • Events
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Documents & Charters
    • Leadership Team
    • Board of Directors
    • Committee Composition
  • Financial & Filings
    • SEC Filings
    • Annual Reports and Proxy Satements
  • IR Resources
    • Email Alerts
    • Contact IR
  • Contact Us
Menu - sns
Twitter Linkedin

Investor Relations

SEC Filings

Filing date Form Description Filing Group View
Mar 10, 2021 10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML
0001213900-21-014633.pdf
0001213900-21-014633.rtf
0001213900-21-014633.xls
EX-101.INS - XBRL INSTANCE FILE
Mar 31, 2022 10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML
0001213900-22-016849.pdf
0001213900-22-016849.rtf
0001213900-22-016849.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jan 25, 2023 10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML
0001213900-23-005085.pdf
0001213900-23-005085.rtf
0001213900-23-005085.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Mar 31, 2022 10-K/A

Amendment to a previously filed 10-K

Annual Filings
View HTML
0001213900-22-016826.pdf
0001213900-22-016826.rtf
0001213900-22-016826.xls
EX-101.INS - XBRL INSTANCE FILE
Nov 05, 2020 10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
View HTML
0001213900-20-035161.pdf
0001213900-20-035161.rtf
0001213900-20-035161.xls
EX-101.INS - XBRL INSTANCE FILE
May 17, 2021 10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
View HTML
0001213900-21-027102.pdf
0001213900-21-027102.rtf
0001213900-21-027102.xls
EX-101.INS - XBRL INSTANCE FILE
Aug 16, 2021 10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
View HTML
0001213900-21-043010.pdf
0001213900-21-043010.rtf
0001213900-21-043010.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Nov 12, 2021 10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
View HTML
0001213900-21-058679.pdf
0001213900-21-058679.rtf
0001213900-21-058679.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
May 13, 2022 10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
View HTML
0001213900-22-026427.pdf
0001213900-22-026427.rtf
0001213900-22-026427.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Aug 15, 2022 10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
View HTML
0001213900-22-047919.pdf
0001213900-22-047919.rtf
0001213900-22-047919.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »
Displaying 1 - 10 of 124 results

Data provided by Kaleidoscope.

Orchestra BioMed logo
  • Footerlink - who we are

    Who We Are Our Approach Our People Careers
  • Footerlink - our innovations

    Our Innovations Pipeline Therapeutic Areas Virtue® SAB BackBeat CNT™ FreeHold Retractors
  • Footerlink - news & events

    Investor Relations Overview News & Events Stock Information Corporate Governance Financial & Filings IR Resources
  • Footerlink - contact us

    Contact Us
Menu - sns
Twitter Linkedin

© 2023 Orchestra BioMed Inc. Virtue®, BackBeat CNT™ FreeHold Duo®, FreeHold Trio® and Orchestra BioMed™ are trademarks of Orchestra BioMed.
All other trademarks are trademarks of their respective owners.
SM-0020 Rev 01

Btn - disclaimer

Disclaimer